SG Americas Securities LLC Buys 86,723 Shares of Agilon Health, Inc. $AGL

SG Americas Securities LLC grew its stake in shares of Agilon Health, Inc. (NYSE:AGL) by 60.1% during the 2nd quarter, Holdings Channel reports. The firm owned 230,912 shares of the company’s stock after buying an additional 86,723 shares during the period. SG Americas Securities LLC’s holdings in Agilon Health were worth $531,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the stock. Cerity Partners LLC grew its stake in shares of Agilon Health by 137.6% in the first quarter. Cerity Partners LLC now owns 43,133 shares of the company’s stock valued at $187,000 after buying an additional 24,977 shares in the last quarter. Private Advisor Group LLC lifted its stake in Agilon Health by 49.9% in the first quarter. Private Advisor Group LLC now owns 53,254 shares of the company’s stock valued at $231,000 after acquiring an additional 17,731 shares during the last quarter. Y Intercept Hong Kong Ltd bought a new position in shares of Agilon Health in the 1st quarter valued at about $193,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Agilon Health during the 1st quarter worth about $587,000. Finally, XTX Topco Ltd increased its stake in shares of Agilon Health by 26.1% during the 1st quarter. XTX Topco Ltd now owns 58,660 shares of the company’s stock worth $254,000 after purchasing an additional 12,133 shares during the last quarter.

Agilon Health Trading Up 4.2%

Agilon Health stock opened at $0.67 on Thursday. The company has a market capitalization of $276.11 million, a price-to-earnings ratio of -0.89 and a beta of 0.05. Agilon Health, Inc. has a 12 month low of $0.51 and a 12 month high of $6.08. The stock’s 50 day moving average is $0.88 and its 200-day moving average is $1.52.

Agilon Health (NYSE:AGL) last released its quarterly earnings results on Tuesday, November 4th. The company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.18) by ($0.09). Agilon Health had a negative return on equity of 75.92% and a negative net margin of 5.24%.The firm had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.43 billion. Agilon Health has set its FY 2025 guidance at EPS. As a group, equities research analysts predict that Agilon Health, Inc. will post -0.59 earnings per share for the current fiscal year.

Analysts Set New Price Targets

AGL has been the subject of a number of research analyst reports. Wells Fargo & Company reduced their price target on Agilon Health from $1.50 to $1.00 and set an “overweight” rating for the company in a report on Wednesday, November 5th. Barclays cut their price objective on Agilon Health from $1.50 to $1.00 and set an “underweight” rating for the company in a research report on Thursday, November 6th. Robert W. Baird decreased their target price on Agilon Health from $5.00 to $1.00 and set a “neutral” rating on the stock in a report on Thursday, August 14th. Jefferies Financial Group dropped their price target on Agilon Health from $2.40 to $1.10 and set a “hold” rating on the stock in a research note on Friday, August 15th. Finally, Zacks Research raised Agilon Health from a “strong sell” rating to a “hold” rating in a report on Tuesday, October 21st. Four research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $2.73.

Agilon Health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.